大肠癌错配修复基因hMLH1突变与微卫星不稳二维DNA电泳及DNA测序技术的意义(英文)  

Detection of mutation of mismatch repair gene hMLH1 in colorectal carcinomas with microsatellite instability by two-dimensional DNAelectrophoresis and DNA sequencing

作　　者：房殿春[1] 汪荣泉[1] 杨仕明[1] 彭贵勇[1] 肖天利[1] 罗元辉[1] 

机构地区：[1]解放军第三军医大学西南医院消化科,重庆市400038

出　　处：《中国临床康复》2005年第47期162-164,共3页Chinese Journal of Clinical Rehabilitation

基　　金：国家自然科学基金资助项目(30070043);全军"十五"重点基金资助(01Z075)~~

摘　　要：背景微卫星不稳是一种重要的基因改变方式,在肿瘤的发生中起重要作用,其发生是由于错配修复基因发生缺陷所致。错配修复基因hM LH1突变在遗传性非息肉性大肠癌中的作用已有报道,但在散发性大肠癌的作用尚缺乏深入的研究。目的探讨错配修复基因hM LH1突变在大肠癌发生中的作用及与微卫星不稳的关系。设计单一样本实验。单位解放军第三军医大学西南医院消化科。材料76例大肠癌及相应正常组织均为2001-01/2003-12西南医院外科手术切除标本,所有患者均无肿瘤家族史,并未接受过放疗和化疗,对实验知情同意。方法采用二维DNA电泳和DNA测序技术检测hM LH1突变;采用聚合酶链反应为基础的方法检测微卫星不稳。主要观察指标①大肠癌hM LH1突变及微卫星不稳检出率。②微卫星不稳与hM LH1突变的关系。结果①76例大肠癌中检出hM LH1基因突变8例,突变率为10.5%,检出微卫星不稳20例,检出率为26.3%。右侧大肠癌hM LH1突变和微卫星不稳的检出率显著高于左侧大肠癌(6/26比2/50,χ2=4.739,P=0.029;11/26比9/50,χ2=5.212,P=0.022),hM LH1突变和微卫星不稳与肿瘤大小、分化程度、组织学类型、浸润深度、淋巴结转移和临床病理分期无显著相关。②将微卫星不稳分为高频率微卫星不稳(≥2个位点)10例、低频率微卫星不稳(仅为1个位点)10例和微卫星不稳阴性56例3组,8例hM LH1基因突变均发生于高频率微卫星不稳组,而低频率微卫星不稳和微卫星不稳阴性组未见有突变者。结论hM LH1基因突变与微卫星不稳多发生于右侧大肠癌,hM LH1突变与高频率微卫星不稳大肠癌的发生有关。BACKGROUND： Microsatellite instability （MSI）, an important gene change type, plays an important role in the occurrence of tumor. Mismatch repair gene induces its occurrence. Although the effect of mismatch repair gene hMLH1 mutation in the hereditary nonpolyposis eoloreetal cancers （HNPCC） has been reported, its effect on the sporadic eoloreetal carcinoma lacks in-depth study. OBJECTIVE： To investigate the effect of mismatch repair gene hMLH1 mutation on eoloreetal carcinogenesis, and its correlation with MSI. DESIGN： Single-sample experiment. SETTING： Department of Gastroenterology, Southwest Hospital of Third Military Medical University of Chinese PLA. PARTICIPANTS： Seventy-six cases of sporadic eoloreetal carcinoma and corresponding normal tissues were obtained from surgically resected specimens of eolorectai carcinoma in Southwest Hospital between January 2001 and December 2003. No patients had family history of tumor, or had received radiotherapy and chemotherapy. Patients were informed of the experiment. METHODS： Mutation of hMLH1 was detected by two-dimensional electrophoresis and DNA sequencing; MSI was analyzed by PCR-based methods. MAIN OUTCOME MEASURES： （1） Detection rate of hMLH1 mutation of eoloreetai carcinoma and MSI. （2） The relationship of MSI and hMLH1 mutation. RESULTS： Seventy-six cases of sporadic eoloreetal carcinoma were studied for hMLH1 mutation and MSI. hMLH1 mutation was detected in 8 （10.5%） cases of colorectal carcinomas while MSI was detected in 20 （26.3%） cases of eoloreetai carcinomas. Frequency of hMLH1 mutation and MSI was significantly higher in right colorectai cancer than in left colorec tal cancer （6/26 vs 2/50, X^2=4.739, P=0.029; 11/26 vs 9/50,x^2=5.212, P=0.022）. No association was observed between hMLH1 mutation or MSI and tumor size, differentiation, histological type, depth of invasion, metastasis or clinical pathological stages.（2） MSI was divided into high-frequency group （≥ 2 loci, n=10） and low-frequency group �

关 键 词：肠肿瘤/遗传学 DNA 卫星 电泳 

分 类 号：R735.3[医药卫生—肿瘤]